Additionally, Lys05, a Kir4.1 inhibitor, has shown rapid antidepressant effects in Kir4.1-driven depressive-like phenotypes and various animal models of depression, highlighting Kir4.1 as a potential target for rapid-acting antidepressants [83]. Here, KCNJ10 is linked to major depressive disorder.